Filtros de búsqueda

Lista de obras de Hugo Arias-Pulido

A Phase II study of pulse dose imatinib mesylate and weekly paclitaxel in patients aged 70 and over with advanced non-small cell lung cancer

artículo científico publicado en 2012

A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma

artículo científico publicado en 2013

Absence of epidermal growth factor receptor mutations in cervical cancer

artículo científico publicado en 2007

Adaptive immunity programmes in breast cancer.

artículo científico publicado en 2016

Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma

artículo científico publicado en 2004

Co-expression of GPR30 and ERbeta and their association with disease progression in uterine carcinosarcoma

artículo científico publicado en 2010

Comparative aspects of canine and human inflammatory breast cancer

artículo científico publicado en 2017

DR6 as a diagnostic and predictive biomarker in adult sarcoma

artículo científico publicado en 2012

Differential effects of CD20+ B cells and PD-L1+ immune cells on pathologic complete response and outcome: comparison between inflammatory breast cancer and locally advanced breast cancer patients

artículo científico publicado en 2021

Epidermal growth factor receptor as a biomarker for cervical cancer

artículo científico publicado en 2011

Epigenetic inactivation of TRAIL decoy receptors at 8p12-21.3 commonly deleted region confers sensitivity to Apo2L/trail-Cisplatin combination therapy in cervical cancer.

artículo científico publicado en 2015

Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors.

artículo científico publicado en 2009

Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome

artículo científico publicado en 2003

GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer

artículo científico publicado en 2009

GPR30 predicts poor survival for ovarian cancer

artículo científico publicado en 2009

Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes

artículo científico publicado en 2007

Genetic analysis identifies putative tumor suppressor sites at 2q35-q36.1 and 2q36.3-q37.1 involved in cervical cancer progression

artículo científico publicado en 2003

Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer.

artículo científico publicado en 2006

Human papillomavirus type 18 variant lineages in United States populations characterized by sequence analysis of LCR-E6, E2, and L1 regions.

artículo científico publicado en 2005

Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression

artículo científico publicado en 2008

Insulin-like growth factor 2 expression modulates Taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer.

artículo científico publicado en 2010

Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha

artículo científico publicado en 2008

Lipoxygenase inhibitors suppress intracellular calcium rise induced by ionomycin in rat thymocytes

artículo científico publicado en 1990

Loss of heterozygosity on chromosome 6 in HPV-16 positive cervical carcinomas carrying the DRB1*1501-DQB1*0602 haplotype

artículo científico publicado en 2004

Mapping common deleted regions on 5p15 in cervical carcinoma and their occurrence in precancerous lesions.

artículo científico publicado en 2002

Mesothelin and GPR30 Staining Among a Spectrum of Pancreatic Epithelial Neoplasms

artículo científico publicado en 2011

Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance

artículo científico publicado en 2021

Molecular and epidemiological characteristics of inflammatory breast cancer in Algerian patients.

artículo científico publicado en 2011

Neoadjuvant Intratumoral Immunotherapy with Cowpea Mosaic Virus Induces Local and Systemic Antitumor Efficacy in Canine Mammary Cancer Patients

artículo científico publicado en 2023

Neoadjuvant in situ vaccination with cowpea mosaic virus as a novel therapy against canine inflammatory mammary cancer

artículo científico publicado en 2022

Novel chemotherapy approaches for cervical cancer.

artículo científico publicado en 2009

Oxygen regulates molecular mechanisms of cancer progression and metastasis

artículo científico publicado en 2014

Phase IB study of the combination of docetaxel, gemcitabine, and bevacizumab in patients with advanced or recurrent soft tissue sarcoma: the Axtell regimen

artículo científico publicado en 2011

Proactive Immunotherapeutic Approaches against Inflammatory Breast Cancer May Improve Patient Outcomes

artículo científico publicado en 2022

Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer

artículo científico publicado en 2004

Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression

artículo científico publicado en 2006

Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer.

artículo científico publicado en 2009

Science and technology consortia in U.S. biomedical research: A paradigm shift in response to unsustainable academic growth

artículo científico publicado en 2014

The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome

scientific article published on 01 June 2018

Treatment of Canine Oral Melanoma with Nanotechnology-Based Immunotherapy and Radiation

artículo científico publicado en 2018

Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer.

artículo científico publicado en 2012

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda